about
Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion InjuryCNTF and retinaNegatively Charged Silver Nanoparticles Cause Retinal Vascular Permeability by Activating Plasma Contact System and Disrupting Adherens JunctionSeverity of middle cerebral artery occlusion determines retinal deficits in ratsDiabetic macular edema: new concepts in patho-physiology and treatment.Glucose transport in brain and retina: implications in the management and complications of diabetes.Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina.Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.Chloride intracellular channel 4 is critical for the epithelial morphogenesis of RPE cells and retinal attachmentThe genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.The role of the retinal pigment epithelium: topographical variation and ageing changes.Fluids and barriers of the CNS: a historical viewpointTNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosisDrug delivery to the retina: challenges and opportunities.Nanotechnology and nanotoxicology in retinopathy.Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor.Energy metabolism of the visual system.A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathyNovel approaches to retinal drug delivery.Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Surgical treatment for macular edema.Regulation of claudins in blood-tissue barriers under physiological and pathological statesLectin-ferritin binding on spontaneously diabetic and control rat retinal microvasculature.Anti-angiogenic Therapy for Retinal Disease.Nanocrystal for ocular drug delivery: hope or hype.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Glucose metabolism in mammalian photoreceptor inner and outer segments.Reactive oxygen species downregulate glucose transport system in retinal endothelial cells.Mechanism of ganciclovir uptake by rabbit retina and human retinal pigmented epithelium cell line ARPE-19.Some observations about retinal vascular-neuronal interrelationships.Diffusion Regulation in the Vitreous Humor.Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastomaNoninvasive evaluation of retinal leakage using optical coherence tomography.Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation.Insulin-like growth factor-1 effects on bovine retinal endothelial cell glucose transport: role of MAP kinase.Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells.
P2860
Q28079203-01E9ED97-0FFE-4C77-BB76-B0BEE48CF7C6Q28731691-C93A1ED3-1052-411F-B0D3-4B04A3C1FF57Q29248661-61BD351B-535D-448B-A343-51934A36CA11Q33694100-C59DBF31-8DD0-41CE-A7E4-8111558E5CC6Q33713517-03087B66-73D0-4610-B3FE-CC7FB19C4C2BQ33737742-4086EFE6-EBDF-4FD7-BA97-CEDB4A072A12Q33742338-0C35AAD7-BA81-437F-BAFC-4E15598BC6B7Q33914624-ED5BA83A-2652-4E83-B01E-2CEB1EA19513Q34091246-478C0CAE-4A5F-45C2-8967-09107DCBBE2EQ34291870-5041FFEB-8FF5-456F-99EC-4D03B30DD53DQ34307040-84E040DE-D750-4814-8720-6AE38A9E4F14Q34577621-171A0D24-2E2F-4168-89B7-66891CE19E62Q35005977-2123A1DF-EE57-4F4B-862F-A2901C02A9D7Q35116140-B502E3AE-5986-4BAD-B212-9DED152CCBCAQ35600266-09BDA954-D370-47CC-A5FC-0D11C382A27CQ35795581-78B7BA72-0901-4B8E-B62F-6B9E5843DE42Q36448758-FCBA8FAF-307C-43A2-9017-F0D3622D8818Q36783430-94FFFD84-7942-428C-A506-046232285AC6Q36903801-1212C88A-655E-4FF9-BDF8-F3A0429FAD22Q36921110-2B922476-C686-4236-B19F-C1FE76744FF8Q37425217-3D85DFE8-3CF8-49BE-AD41-D4FA8635D320Q38030642-F5109F7F-20C2-4055-8697-70AB6747F256Q38074311-D891FF75-FB36-4C0E-96E6-FFF3927039B8Q38168361-CC830058-AE3E-4D44-9A52-4B2C5D31E3CCQ38177288-79316384-8760-4153-A958-9CD35BDAF71CQ38199105-D801C9F3-CEC6-4653-A430-863BD1DADEAEQ38345124-7EC21720-4AF9-4D65-B489-033D57508E6AQ38805247-728793EC-2F4E-4349-8820-83322266B5CBQ38831205-AA6BF014-C296-477B-976B-BC1EF4DB35C6Q39103248-2AF75822-8082-419C-BD2E-72B4CEEA370FQ39196189-3B3CEE2A-4470-4627-AB07-8DFBD6260098Q39608625-34943FC7-907E-4533-85A6-7CE664977DB2Q40498731-4772C25B-DB69-4C08-AE15-2AF9A403C2E0Q41775576-AA38A021-5F48-46EE-ABCA-6C574CF15562Q41946889-44498607-616D-4AA1-AFA9-FAD6E4C038D5Q42412771-1F782767-1423-4079-8AEF-B85E8FD958F5Q43443130-0DE0F918-FC20-4DD6-B62C-FCF3C8FC630AQ43612910-81E11176-C314-4E2F-A773-EB316F136071Q44028740-CC45581A-8406-4BA1-9DC5-FC35B7DDEFE5Q44304821-B0C1CF3E-8E7F-4013-9702-998064EBDFED
P2860
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh-hant
name
The blood-retinal barriers.
@en
The blood-retinal barriers.
@nl
type
label
The blood-retinal barriers.
@en
The blood-retinal barriers.
@nl
prefLabel
The blood-retinal barriers.
@en
The blood-retinal barriers.
@nl
P356
P1476
The blood-retinal barriers.
@en
P2860
P2888
P304
P356
10.1007/BF00146764
P577
1976-10-01T00:00:00Z